The melanoma EV-induced up-regulation of ghrelin, a 28-residue peptide hormone that accelerates the growth of MSCs and has an anti-inflammatory activity [49], is consistent with the down-regulation of IL-26, IL-17B, caspase-1 and CCL5. The gene discussed is GHRL; the disease is melanoma.